Pages that link to "Q28205016"
Jump to navigation
Jump to search
The following pages link to NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development (Q28205016):
Displaying 50 items.
- Left auditory cortex gamma synchronization and auditory hallucination symptoms in schizophrenia (Q21262976) (← links)
- Schizophrenia, “Just the Facts”: What we know in 2008 (Q22251476) (← links)
- Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia (Q24306904) (← links)
- The alkaloid alstonine: a review of its pharmacological properties (Q24538432) (← links)
- Dynamic Network Connectivity: A new form of neuroplasticity (Q24597628) (← links)
- Positive allosteric modulation of metabotropic glutamate 5 (mGlu5) receptors reverses N-Methyl-D-aspartate antagonist-induced alteration of neuronal firing in prefrontal cortex (Q24602550) (← links)
- Clozapine, but not haloperidol, enhances glial D-serine and L-glutamate release in rat frontal cortex and primary cultured astrocytes (Q24606088) (← links)
- Neuromodulation of thought: flexibilities and vulnerabilities in prefrontal cortical network synapses (Q24619549) (← links)
- Neural synchrony in schizophrenia: from networks to new treatments (Q24644168) (← links)
- Antidepressant mechanism of ketamine: perspective from preclinical studies (Q26800231) (← links)
- Characterizing thalamo-cortical disturbances in schizophrenia and bipolar illness (Q27303206) (← links)
- Histamine H3 receptors and its antagonism as a novel mechanism for antipsychotic effect: a current preclinical & clinical perspective (Q28073102) (← links)
- Emotional and cognitive dysregulation in schizophrenia and depression: understanding common and distinct behavioral and neural mechanisms (Q28073684) (← links)
- (Q28160830) (redirect page) (← links)
- Marked prevention of ischemic brain injury by Neu2000, an NMDA antagonist and antioxidant derived from aspirin and sulfasalazine (Q28210391) (← links)
- Modulators of the glycine site on NMDA receptors, D-serine and ALX 5407, display similar beneficial effects to clozapine in mouse models of schizophrenia (Q28239090) (← links)
- Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebo-controlled clinical trial in patients on standard treatment (Q28265163) (← links)
- Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects (Q28276986) (← links)
- Feasibility, safety, and efficacy of the combination of D-serine and computerized cognitive retraining in schizophrenia: an international collaborative pilot study. (Q28277784) (← links)
- The ameliorating effects of 5,7-dihydroxy-6-methoxy-2(4-phenoxyphenyl)-4H-chromene-4-one, an oroxylin A derivative, against memory impairment and sensorimotor gating deficit in mice (Q28288084) (← links)
- Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats (Q28297687) (← links)
- Loss of Consciousness Is Associated with Stabilization of Cortical Activity (Q28646085) (← links)
- Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence (Q29618819) (← links)
- Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice (Q30364693) (← links)
- Spontaneous Gamma Activity in Schizophrenia. (Q30377860) (← links)
- Discordant behavioral effects of psychotomimetic drugs in mice with altered NMDA receptor function (Q30386868) (← links)
- Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice (Q30403787) (← links)
- Mismatch negativity (MMN) as an index of cognitive dysfunction (Q30407708) (← links)
- Schizophrenia and Depression Co-Morbidity: What We have Learned from Animal Models (Q30416883) (← links)
- The effects of ketamine and risperidone on eye movement control in healthy volunteers (Q30437913) (← links)
- Auditory steady state responses in a schizophrenia rat model probed by excitatory/inhibitory receptor manipulation (Q30447745) (← links)
- Pathogenic disruption of DISC1-serine racemase binding elicits schizophrenia-like behavior via D-serine depletion (Q30447828) (← links)
- Electrophysiological assessment of auditory stimulus-specific plasticity in schizophrenia (Q30449596) (← links)
- Evidence for involvement of nitric oxide and GABA(B) receptors in MK-801- stimulated release of glutamate in rat prefrontal cortex (Q30450049) (← links)
- The effect of pregabalin on sensorimotor gating in 'low' gating humans and mice. (Q30450055) (← links)
- Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments (Q30457813) (← links)
- Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders (Q30459497) (← links)
- Sex-dependent antipsychotic capacity of 17β-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males (Q30474007) (← links)
- The reelin receptors VLDLR and ApoER2 regulate sensorimotor gating in mice. (Q30496781) (← links)
- Glutamatergic modulation of auditory information processing in the human brain (Q30506046) (← links)
- The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress (Q30651146) (← links)
- Anatomical abnormalities of the anterior cingulate cortex in schizophrenia: bridging the gap between neuroimaging and neuropathology (Q31153621) (← links)
- Biomarkers, designs, and interpretations of resting-state fMRI in translational pharmacological research: A review of state-of-the-Art, challenges, and opportunities for studying brain chemistry (Q31158600) (← links)
- The neurobiology of D-amino acid oxidase and its involvement in schizophrenia. (Q33611796) (← links)
- Pharmacological or genetic orexin1 receptor inhibition attenuates MK-801 induced glutamate release in mouse cortex. (Q33659596) (← links)
- Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats (Q33848200) (← links)
- Psychiatric disorders: diagnosis to therapy (Q33922884) (← links)
- The interactive effects of ketamine and nicotine on human cerebral blood flow (Q33937889) (← links)
- Pharmacological blockade of serotonin 5-HT₇ receptor reverses working memory deficits in rats by normalizing cortical glutamate neurotransmission (Q33942069) (← links)
- Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia (Q33966168) (← links)